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Transcytosis is a widespread pathway for apical
targeting in epithelial cells. MAL2, an essential
protein of the machinery for apical transcytosis,
functions by shuttling in vesicular carriers between
the apical zone and the cell periphery. We have iden-
tified INF2, an atypical formin with actin polymeriza-
tion and depolymerization activities, which is a
binding partner of MAL2. MAL2-positive vesicular
carriers associate with short actin filaments during
transcytosis in a process requiring INF2. INF2 binds
Cdc42 in a GTP-loaded-dependent manner. Cdc42
and INF2 regulateMAL2 dynamics and are necessary
for apical transcytosis and the formation of lateral
lumens in hepatoma HepG2 cells. INF2 and MAL2
are also essential for the formation of the central
lumen in organotypic cultures of epithelial MDCK
cells. Our results reveal a functional mechanism
whereby Cdc42, INF2, and MAL2 are sequentially
ordered in a pathway dedicated to the regulation of
transcytosis and lumen formation.
INTRODUCTION
Epithelial cells organize into spherical or tubular structures with
their apical surface facing a central lumen and the basolateral
surface contacting adjacent cells and the extracellular matrix
(Bryant and Mostov, 2008). Acquisition and maintenance of
apical and basolateral polarity by epithelial cells is fundamental
to the display of a central lumen. Cell polarity requires sorting of
lipids and proteins and subsequent vectorial traffic to their
specific surface destinations (Mellman and Nelson, 2008).
Proteins destined for the apical surface travel directly from
the Golgi or indirectly by making a detour to the basolateral
surface before becoming internalized and transported through
the cell in specialized endosome carriers in a process known
as transcytosis. Apical transport in epithelial cells relies on
the use of these direct and indirect pathways to different814 Developmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Indegrees, depending on the type of tissue (Rodriguez-Boulan
et al., 2005).
Hepatocytes are specialized epithelial cells that delimit a
lumen structured into tiny channels, the bile canaliculi, which is
used for bile drainage. Unlike columnar epithelial cells, whose
luminal domain is located at the cell’s apex and forms a central
lumen, the luminal domain of hepatocytes is present in the lateral
surface and delimits a bile canaliculus. Lumen positioning is
regulated by Par1, which regulates the organization of themicro-
tubule network (Cohen et al., 2004). MAL2 is an integral mem-
brane protein originally identified in a yeast two-hybrid screen
by its interaction with tumor protein D52 (Wilson et al., 2001),
the founder member of a family of proteins frequently overex-
pressed in breast carcinoma (Boutros et al., 2004). MAL2 has
proved to be an essential element of the machinery for basolat-
eral-to-apical transcytosis in the HepG2 cell line (deMarco et al.,
2002), a model of the hepatic cell. At steady state, MAL2
predominantly distributes in a Rab11+ subapical endosome
compartment in both HepG2 cells (de Marco et al., 2002, 2006)
and epithelial cells (Marazuela et al., 2004). Soon after basolat-
eral endocytosis of apical cargo, a fraction of MAL2 redistributes
from the apical region into peripheral endosome elements to
concentrate internalized cargo. These endosomes then progres-
sively fuse andmove toward the apical surface for cargo delivery
(de Marco et al., 2006).
Formins are a widely expressed family of proteins that
nucleate the formation of actin filaments. Unlike the actin-related
protein 2/3 (Arp2/3) complex, which generates branched fila-
ments, formins form linear filaments (Ridley, 2006). The best-
studied formins are the diaphanous-related formins (Drfs), which
are direct effectors of Rho-family GTPases (Goode and Eck,
2007). Drfs have at their carboxyl terminus an autoregulatory
domain, known as the diaphanous autoregulatory domain
(DAD), which is separated by formin homology (FH) domains
1-2 from an amino-terminal diaphanous inhibitory domain
(DID). The DAD interacts with the DID to close the Drf molecule
and maintains it in an inactive state. The binding of the effector
Rho GTPase regulates Drf activity by opening up the Drf mole-
cule (Otomo et al., 2005). Drfs have been found to modulate
a number of intracellular processes, such as endosome motility,
microtubule stabilization, and cytokinesis (Faix and Grosse,
2006).c.
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sought proteins that interact with MAL2 and have identified
human inverted formin (INF) 2, a formin organized in DID,
FH1-2, and DAD domains, which has the unique ability to accel-
erate both actin polymerization and depolymerization (Chhabra
and Higgs, 2006). The results presented in this work indicate
the existence of a novel pathway by which Cdc42 controls apical
transcytosis and correct lumen formation by regulating MAL2
dynamics through INF2.
RESULTS
Identification of Human INF2 as a MAL2-Interacting
Formin
A yeast two-hybrid screen of a breast carcinoma cDNA expres-
sion library was performed with a full-length MAL2 bait (Fanayan
et al., 2009). One of the cDNAs isolated, named 255C1, corre-
sponds to a partial cDNA encoding the 255 carboxy-terminal
amino acids of the human INF2-1 formin (see Figures S1A and
S1B available online). Human INF2-1 consists of a 1249 residue
sequence (Figure S1B) organized into DID, FH1-2, DAD, and
a carboxy-terminal (C) domain, as described for mouse INF2-1
(Chhabra and Higgs, 2006). The 255C1 INF2-1 prey reproducibly
bound full-length MAL2 and deleted MAL2 baits lacking the
N-terminal domain (MAL2DN) or the N-terminal and the first
membrane-associated domains (MAL2DNTM1), but did not
detectably bind a deleted MAL2 bait additionally lacking the
second membrane-associated domain (MAL2DNTM12) (Fig-
ure 1A). These results indicate that MAL2 residues S56–F86
that include the second hydrophobic segment are required for
INF2-1 binding in this assay. In addition to INF2-1, whose C
domain ends with a CIVQ sequence that in mouse INF2-1 is
farnesylated (Chhabra et al., 2009), a second INF2 cDNA was
found to encode an isoform, INF2-2, in which the last 18 amino
acid sequence of the INF2-1 carboxyl terminus was substituted
by a 9 amino acid sequence containing basic amino acids
(Figures S1A and S1B). The primary structure of human INF2-1
is 73% identical to that of mouse INF2-1 (Figure S1C). The great-
est differences occur within the FH1 domain, which is shorter in
human INF2, and in the C domain. Phylogenetic analysis indi-
cated that INF2 is more closely related to Drfs Dia 1–3 than to
other formins (Figure S1D). Northern blot analysis of different
human tissues suggested that INF2 mRNA is ubiquitously ex-
pressed (Figure S1E). The antibodies generated to two INF2
peptides detected endogenous INF2 in a panel of human cell
lines and in Madin-Darby canine kidney (MDCK) cells (Figures
S1F–S1H).
Consistent with the results of yeast two-hybrid experiments,
MAL2 bound to an INF2-1 fragment containing most of the C
domain in pull-down experiments using a GST fusion (Figure 1B).
A similar result was obtained with the similar fragment of INF2-2.
The FH2DAD fragment, which contains the initial amino acids of
the C domain, also bound MAL2, although it did so to a lesser
extent than did the GST-C fusions. Coimmunoprecipitation
experiments confirmed the association of INF2 and MAL2
(Figure 1C).
HepG2 cells polarize in vitro with their apical surface, forming
intercellular lumens reminiscent of bona fide bile canaliculi (Sor-
munen et al., 1993). The fact that polarized apical trafficking inDevehepatic cells is simpler than in other model cell lines (Bastaki
et al., 2002) led us to choose HepG2 cells for the functional study
of INF2. A small fraction of endogenous INF2 colocalized with
MAL2 at the apical membrane of HepG2 cells, whereas the
remaining INF2distributed throughout the cytoplasm (Figure 1D).
Exogenous INF2-1 and INF2-2 reproduced the presence of
endogenous INF2 at the apical membrane (Figure 1E), INF2-1
being mostly distributed in the endoplasmic reticulum, as
described for mouse INF2-1 (Chhabra et al., 2009). Although a
high level of colocalization between INF2 and calnexin was
observed at the endoplasmic reticulum, calnexin was nearly
depleted at the canalicular zone whereas INF2 was still present
(Figures S1I and S1J). In keeping with its interaction with
MAL2, the C domain of INF2-1 and INF2-2 continued to target
to the apical region, as observed for the entire molecule
(Figure 1F). Therefore, the C domain is the main determinant of
the interaction of INF2 with MAL2 and the targeting of INF2 to
the apical zone.
INF2 Silencing Impairs Lumen Formation,
MAL2 Targeting to the Apical Surface,
and Basolateral-to-Apical Transcytosis
To investigate the possible role of INF2 in MAL2 localization and
function, we used a loss-of-function strategy by employing
specific siRNA1 (si1) or siRNA2 (si2) targeted to the 30 untrans-
lated or coding regions of human INF2 mRNA, respectively.
Expression of si1 or si2 reduced the levels of endogenous INF2
to approximately 7% or 15%, respectively, of the INF2 content
of control siRNA (siC)-transfected cells (Figures 2A and 2B).
INF2 silencing greatly diminished the number of intercellular
lumens (Figure 2C), decreased the size of the remaining lumens
(Figure 2D), and caused a reduction in the levels of MAL2 at
the apical zone in these lumens (Figures 2E and 2F). The loss
of MAL2 from the apical zone was compensated for by its
increased presence in scattered vesicular structures (Figure 2F).
MAL2 was previously shown to be essential for efficient trans-
cytosis to the apical surface of both the polymeric immunoglob-
ulin receptor and CD59, which are attached to the membrane
by a single anchor, a transmembrane spanor a glycosylphospha-
tidylinositol moiety, respectively (de Marco et al., 2002). As INF2
depletion affects the apical distribution of MAL2, we investigated
whether transcytosis takes place in the absence of INF2 expres-
sion by analyzing the transport of CD59 to the luminal surface.
Whereas approximately 75% of the intercellular lumens were
scored as positive for transcytosed CD59 in siC-treated cells
after 90 min of transcytosis, the percentage dropped to 35%–
40% in the remaining lumens of INF2-silenced cells (Figure 2G;
Figure S2A). Moreover, the levels of transcytosed CD59 were
greatly diminished in INF2-silenced cells even in the lumens
scored as positive for CD59 transcytosis (Figure 2H). The inter-
nalized CD59 in INF2-depleted cells accumulated in endosome
structures distant from the apical membrane (Figure S2B),
similar to the pattern observed in MAL2-silenced cells (de Marco
et al., 2002). The number and size of the lumens, the levels of
apical MAL2, and the access of CD59 to the apical membrane
were closely associated with INF2 expression, as confirmed in
HepG2 cells expressing intact INF2-2 proteins designed to be
resistant (HepG/R1 cells) or sensitive (HepG/S1 cells) to expres-
sion of si1 but sensitive to si2 expression (Figure 2; Figure S2C).lopmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Inc. 815
BD E
A
+
++MAL2ΔN
++++MAL2
Vector only
D52/D53/D54255C1Vector onlyPreys→
Baits↓
MAL2ΔNTM1
MAL2ΔNTM12 --
-
--
-
--
-
-
5 μm
GFP-C2 
MAL2INF2
1
35
87
56
MAL2
ΔN
ΔNTM1
ΔNTM12
TM TM
TM TM
TM TM
TM TM
TM TM
TM TM
TM
R=0.54INF2
MAL2
2  μm
+0.71
-0.71
INF2
MAL2
10 μm
F-actin
DIC
GFP-C1
GFP-C1
F-actin
GFP-C2
F-actin
10 μm
S I S I S I S I
GST
input
__ 15
MAL2
C1
FH2DAD
FH1FH3 FH2DID
1012
INF2
C2
1249
D
C1 C2 FH2DAD
↓
554 940
973 990
534
1015
12401015
C
N C
INF2 
MAL2 
input IP
MDCK HeLa
C
FH2
INF2 
αTub
INF
2-1
GFP 
αTub
C1 C2
F
endog.
INF2-2
INF2-1
%
 IN
F2
100
0
200
10 μm 5 μm
INF2-2
F-actin
10 μm
INF2-2 
5 μm
F-actin
DIC
F-actin
DIC
F-actin
DIC
INF
2-2
en
do
g.
αTub
input IP
__ 15
__ 50
INF2 
__50
__50
__50
__50
__150
__150
in
out
10 μm
10 μm10 μm
***
***
D
INF2-1 
5 μm
INF2-1
F-actin
F-actin
DIC
10 μm
10 μm
Figure 1. Characterization of INF2 as a
MAL2-Interacting Protein and Analysis of
Its Subcellular Distribution
(A) Yeast HF7C strain cells were cotransformed
with the pAD-GAL4 255C1 cDNA obtained in the
yeast two-hybrid screen and bait constructs en-
coding either full-length MAL2 or the indicated
MAL2 proteins. Yeast growth on solid media at
30C was evaluated as follows: –, no growth after
6–8 days; + or ++, growth after 5-6 or 3-4 days,
respectively. Interactions between full-length
MAL2 and D52-like prey proteins were employed
as controls. Identical results were obtained for all
three D52-like (D52, D53, and D54) baits, which
were grouped together in a single column. A sche-
matic of the predicted structure of MAL2 is shown.
(B) MAL2-enriched (I) or -depleted (S) membrane
fractions obtained from HepG2 cells were sub-
jected to pull-down analysis with GST fusions of
the C domain of INF2-1 (C1) or of INF2-2 (C2) or
the FH2DAD fragment of INF2. The presence of
MAL2 was determined by immunoblotting.
(C) An MDCK cell lysate was immunoprecipitated
with anti-MAL2 antibodies and the immunoprecip-
itates were immunoblotted with antibodies to
INF2, MAL2, or a-tubulin. HeLa cells, which
express INF2 but notMAL2, were used as a control
of the immunoprecipitation procedure.
(D) HepG2 cells were stained for endogenous
INF2, MAL2, and F-actin. An image reconstructed
from different confocal planes is shown (top left
panel). The position of the lumen is indicated by
the boxed region. The enlargement of the boxed
region shows the individual distribution of INF2
and MAL2 at the apical zone in a single x-y plane
(middle panels) and the merged image (bottom
left panel). Pixels where INF2 and MAL2 colocalize
are depicted in a false-color image obtained by
intensity correlation analysis (bottom right panel).
The numbers on the false-color scale are intensity
correlation coefficients. R indicates Mander’s
colocalization value for MAL2 and INF2 at the
apical zone.
(E and F) HepG2 cells stably expressing
Myc-tagged forms of INF2-1 or INF2-2 (E) or tran-
siently expressing GFP fusions of the C domain of
INF2-1 or INF2-2 (F) were used to analyze the
distribution of exogenous INF2 proteins and
F-actin. A representative image reconstructed
from different confocal planes (E) or a single
confocal x-y plane (F) is shown in the left panels. An enlargement of the apical zone from a single equatorial x-y plane (boxed region) is shown on the right of
each panel. A Nomarsky image of the cell field is also included. The expression levels of INF2-1 and INF2-2 (E) and those of C1 and C2 (F) were analyzed by
immunoblotting. The histogram in (E) shows the percentage of INF2-1 and INF-2 expression relative to endogenous (endog.) INF2. The mean ± SEM from three
independent experiments is shown (***p < 0.001). See also Figure S1.
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INF2 Mediates Transcytosis and Lumen FormationThe exogenous expression of mDia1 (Figure S2D) was unable
to correct the defects observed in lumen formation in INF2-
silenced cells (Figure 2C), confirming the specific requirement
of INF2. These results indicate that INF2 is required for lumen
formation and efficient transcytosis to the apical membrane of
HepG2 cells.
INF2 Silencing Impairs the Translocation
of Apical MAL2 to Encounter Internalized Cargo
MAL2 mediates transcytosis by emitting vesicles and tubular
extensions from the apical region to encounter internalized cargo816 Developmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Indispersed at the basolateral periphery (de Marco et al., 2006). To
investigate whether INF2 is required for MAL2 redistribution, we
compared the dynamics of MAL2 in normal and INF2-silenced
cells during CD59 transcytosis in HepG2 cells stably expressing
GFP-MAL2 (HepG2/GFP-MAL2). MAL2 was initially detected
solely in the luminal area in normal and INF2-silenced cells but,
whereas emission of MAL2 tubules and vesicles to the cell
interior took place by maturation of buds, in INF2-silenced cells
buds formed but did not detach efficiently (Figures 3A and 3B;
Movie S1). Different endosome profiles labeled for MAL2,
F-actin, and internalized CD59 or endogenous INF2 werec.
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Figure 2. INF2 Silencing Decreases the Apical Levels of MAL2 and Apical Transcytosis
The three types of HepG2 cells were transfected with the indicated siRNA for 72 hr and subjected to different processing.
(A) Cells were processed for immunofluorescence labeling of INF2. The intensity of the staining was measured in >50 cells per experiment. The histogram repre-
sents the percentage of the INF2 signal relative to the corresponding siC-transfected cell.
(B) Cells were lysed and subjected to immunoblottingwith anti-INF2 or anti-a-tubulin antibodies. The numbers under the INF2 blot indicate the percentage of INF2
levels, as measured by densitometric analysis, relative to the corresponding siC-transfected cell. The histogram on the right represents the total levels of INF2
in HepG/R1 and HepG/S1 cells expressed as the percentage relative to the INF2 content in siC-treated HepG2 cells.
(C) The number of intercellular lumens in the different cell cultures was quantified by analyzing 100 cells per experiment. A control with normal HepG2 cells
expressing si2 for 72 hr and then expressing exogenous mDia1 for 24 hr is included.
(D) The diameter of the lumen in the different cell cultures was determined by analyzing at least 100 cells per assay. The result of a representative experiment and
the mean from three independent experiments are shown.
(E) The fluorescence intensity of MAL2 at the apical region was quantified in >25 lumens in each type of cell per experiment. The result is expressed as the
percentage fluorescence intensity of apical MAL2 relative to that in siC-transfected cells.
(F) A representative example of the overall distribution ofMAL2 under the different conditions. A single confocal x-y plane is shown. Enlarged details of the staining
at the luminal zone within the boxed regions are shown. INF2 staining was done in parallel. The contour of the lumens, obtained from phase-contrast images, is
indicated by dotted lines. This experiment was done in parallel with the silencing analysis shown in (B).
(G and H) The number of lumens scored as positive for transcytosed CD59 after 60 or 90 min of transcytosis (G) and the intensity of CD59 staining in the positive
lumens were determined (H). At least 50 lumens were analyzed in each case. Data are expressed as the percentage of CD59-positive lumens (G) or the levels of
transcytosed CD59 expressed as the percentage relative to those in siC-transfected normal HepG2 cells (H).
Data in (A)–(E), (G), and (H) are summarized as means ± SEM from three independent experiments (*p < 0.05; **p < 0.01; ***p < 0.001). See also Figure S2.
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Figure 3. INF2 Silencing Impairs the Redistribution of Apical MAL2 to Meet Cargo for Apical Transcytosis
(A and B) HepG2/GFP-MAL2 cells with either normal (A) or silenced levels (B) of INF2 were sequentially incubated with anti-CD59 and fluorescent anti-mouse IgG
antibodies at 4C, washed, and incubated at 37C to allow transcytosis of CD59. After 10 min, cells underwent time-lapse videomicroscopy to detect MAL2 and
CD59 (A) or MAL2 (B). Selected sequential frames from a representative experiment are shown. The asterisks indicate the position of the lumen. The arrows point
to MAL2-positive buds and elements that arise from the apical region, and the arrowheads indicate MAL2-positive structures emitted from the luminal zone that
are positive for internalized CD59. See also Movie S1.
(C–E) Still images obtained by confocal microscopy of different events occurring early during transcytosis. The enlargements show details of the boxed regions
indicating the positions of MAL2 (filled arrow), actin filaments (arrowhead), and internalized CD59 (open arrow) (C) or INF2 (open arrow) (D and E) after 20 min of
transcytosis. The asterisks in (C) indicate the position of the lumen. A single confocal x-y plane is shown.
(F) The number of cytoplasmicMAL2-positive elements with associated actin comets was quantified and represented asmean ± SEM. Three independent exper-
iments were performed (***p < 0.001).
(G) Schematic representation of different events visualized during transcytosis. AMAL2-positive bud detaching from the apical region (box 1) and aMAL2-positive
vesicle approaching (box 2) or fusing (box 3) with an endosome vesicle containing basolaterally internalized CD59.
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INF2 Mediates Transcytosis and Lumen Formationcaptured early during CD59 transcytosis. Figure 3C shows a
MAL2-positive bud arising from the apical zone that is sur-
rounded by F-actin at the site of bud attachment (box 1), a
MAL2-positive element with a short actin comet encountering
a vesicle loaded with internalized CD59 in the middle of the cell
(box 2), and a MAL2-positive profile emitting extensions to
contact a vesicle with internalized CD59 at the cell periphery
(box 3). Figures 3D and 3E show a MAL2-positive apical bud
associated with INF2 and F-actin and a peripheral MAL2-posi-
tive transport vesicle with INF2 and an associated actin comet,
respectively. It is of particular note that silencing of INF2 greatly
reduced the number of cytoplasmic MAL2-positive vesicular
elements associated with actin comets (Figure 3F). Therefore,
INF2 is required for the formation of actin comets that allow
the emission of MAL2-positive elements from the apical
membrane and their movement to encounter basolaterally inter-
nalized cargo (Figure 3G).
INF2 Function in Transcytosis Is Lost by Mutation
of Critical Residues Involved in Actin Polymerization
or Depolymerization
Mutation of three critical leucine residues (Leu1010, Leu1011,
Leu1020) to alanine in the DAD of mouse INF2 abrogates the
in vitro depolymerization but not the polymerization activity of
INF2 (Chhabra and Higgs, 2006). Substitution of Lys1601 in the
FH2 domain of yeast formin Bni1p and of the corresponding
lysine residue of mDia2 (Lys853) by alanine abolishes the actin
nucleation activity of these formins (Bartolini et al., 2008; Xu
et al., 2004). As all these residues are conserved in human
INF2 (Figure 4A), we introduced the same replacements at the
equivalent positions of human INF2-2 (Lys792 and Leu976,
Leu977 and Leu986) to express INF2 proteins (INF2-K/A and
INF2-3L/A) with these mutations. As transient overexpression
of INF2-3L/A was toxic to the cells, we prepared stable transfec-
tants, whereas in the case of INF2-K/Awe used transient expres-
sion. We then examined whether INF2-3L/A or INF2-K/A, which
were designed to resist si1 but not si2 expression, as actually
occurred (Figure 4A), can functionally replace endogenous
INF2 in si1-transfected cells as intact INF2-2 did (Figure 2). The
stable expression of INF2-3L/A produced a 40% reduction in
the number of intercellular lumens relative to normal HepG2 cells
(Figure 4B). Silencing the endogenous protein alone with si1 in
HepG2 INF2-3L/A cells caused an additional 20% decrease,
and knockdown of both the endogenous and the exogenous
protein with si2 produced a further 8% drop (Figure 4B). The
failure of INF2-3L/A to replace endogenous INF2 in lumen forma-
tion parallels its ineffectiveness in mediating CD59 transcytosis
(Figures 4C–4E) and is correlated with a significant reduction in
the number of cytoplasmic MAL2-positive vesicles associated
with actin comets (Figure 4F). Similarly, the INF2-K/A mutant
was also unable to replace endogenous INF2 in lumen formation,
apical transcytosis, and association of actin comets to MAL2-
positive vesicles, although the effects of INF2-K/A were milder
than those of the INF2-3L/A mutant (Figures 4B–4F). Thus,
INF2 requires its actin depolymerization activity and an intact
FH2 domain to mediate normal lumen formation and efficient
transcytosis in HepG2 cells.
Next, we carried out gain-of-function experiments by express-
ing DDID and DDIDDC INF2-2 proteins lacking the DID domain,Devewhich is required for closing Drfs in an inactive state. Expression
of both mutants in HepG2 cells (Figure 4G) induced formation of
long longitudinal actin stress fibers (Figure S3A), alignment of
microtubules along the actin fibers (Figure S3A), cell depolariza-
tion (Figure S3B), and development of long filopodial structures
(Figures 4H–4J; Figures S3A–S3C). Filopodia induced by the
mutants were often long, up to 6–8 mm (Figure 4H), and were
not attached to the substratum, resembling those induced by
an mDia2 mutant with a similar N-terminal deletion (Yang et al.,
2007). Cell depolarization and formation of long filopodia were
also induced by the two INF2-2 deletion mutants in MDCK cells
(Figures S3D–S3G). Both mutants were detected at the tip of
most of the filopodium processes present in transfected
HepG2 cells (Figure 4I, left histogram; Figure 4J). It is of particular
note that the distribution of MAL2 in these cells was affected
differently by the mutants. DDID INF2-2, which keeps the
MAL2-interacting C region intact, induced the recruitment of
MAL2 to the F-actin tips at the cell edges, where MAL2 and
the DDID mutant colocalized, whereas DDIDDC INF2-2, which
lacks the MAL2-interacting C region, did not target MAL2 to
the F-actin tips (Figure 4I, right histogram; Figure 4J). As
a control, we observed that expression of intact INF2-2 did not
alter the perinuclear MAL2 distribution found in the unpolarized
population of HepG2 cells (Figure 4J). The results in Figures
4H–4J provide an extreme case showing that the intracellular
distribution of MAL2 is governed by INF2 through the formation
of actin filaments and its physical interaction with MAL2.
Cdc42 Binds INF2 and Regulates Lumen Formation,
MAL2 Dynamics, and Apical Transcytosis
To investigate the binding of RhoGTPases to the DID of INF2, we
performed pull-down assays (Figure 5A). Cdc42 bound to the
INF2 fragment exclusively in its GTP-loaded form, whereas
Rac1 binding occurred regardless of its state of loading,
although to different extents. No binding of RhoA was observed
in either case, consistent with the fact that INF2 lacks an exten-
sion N-terminal to the DID (Chhabra et al., 2009) that is present in
the RhoA-regulated DrfsmDia1-2 and that inmDia1 is involved in
RhoA binding (Otomo et al., 2005). The silencing of Cdc42 basi-
cally reproduced the effects of INF2 silencing with regard to the
number of lumens, the percentage of remaining lumens with
transcytosed CD59, and the levels of transcytosed CD59 in
these lumens (Figures 5B–5F). In contrast, RhoA and Rac1
silencing did not affect the number of lumens or the percentage
of lumens with transcytosed CD59 (Figures 5B–5F) and pro-
duced only mild effects on the luminal levels of transcytosed
CD59 (Figure 5E). Therefore, Cdc42 appears to be the Rho-GT-
Pase regulator of INF2 for the processes of lumen formation and
apical transcytosis, although we cannot rule out a role for Rac1
as an INF2 regulator in other cellular processes.
It is of particular note that a fraction of active Cdc42 mutant
(Cdc42L61) was distributed at the apical membrane where it
colocalized with MAL2, the remainder being distributed
throughout the cytosol (Figure 6A). In accordance with the
results from Cdc42-silenced cells, overexpression of a domi-
nant-negative form of Cdc42 (Cdc42N17) in HepG2 cells
dramatically reduced the number of lumens, whereas the active
mutant had the opposite effect (Figure 6B). Moreover,
Cdc42L61 accelerated CD59 transcytosis in such a way that,lopmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Inc. 819
A siC si2si1
     ---AA--------A--3L/A
siC
mINF2
hINF2
3L/A
αTub
1007 IDALLADIRKGFQLRK 1022
973  IDALLADIRKGFQLRK 988
150
50
G
ΔDID
ΔDID
ΔC
GFP-MAL2/INF2/F-actin F-actin
ΔDID
ΔDIDΔC
FH2FH1 D
266
FH1 FH2 D
1240
266 1012
B C
E
**
*
ΔDID
ΔDIDΔC
%
 M
A
L2
-a
ct
in
 ti
ps
/c
el
l
+
%
 IN
F2
-a
ct
in
 ti
ps
/c
el
l
+
0
20
40
60
80
100
0
20
40
60
80
100
J
H
0
10
20
30
40
50
ΔDID
ΔDIDΔC
Control
INF2-2
N
um
be
r o
f l
um
en
s
GFP-MAL2 INF2
Endog.
INF2 
αTub
ΔD
ID
ΔD
ID
ΔC
GFP
MAL2
IN
F2
-2
↓
**
*
**
*
150
50
50
75
INF2-2
CD59
INF2
F-actin
Merge
CD59
INF2
F-actin
Merge
HepG2-3L/A
si1
3 μm
3 μm
3 μm
10 μm
10 μm
10 μm
5 μm
5 μm
F
0
2
4
6
8
INF2-2
ΔDID
***
Le
ng
th
 o
f f
ilo
po
di
a 
(μ
m
)
C
on
tro
l
I
***
ΔDIDΔC
HepG2-K/A
     -------A--------
1594 LQRLTFIKDTTNSMTF 1609
 846 LCKLKDTKSADQKTTL 861
 785 LLKLTETKSQQNRVTL 800
K/A
αTub
siC
si2
si1
0
20
40
60
80
100
**
***
*
 %
 C
D
59
   
lu
m
en
s
+
3L/AWT K/A
*
**
*
0
5
10
15
20
25
N
um
be
r o
f l
um
en
s
**
**
*
**
*
3L/AWT K/A
D
**
*
**
*
Tr
an
sc
yt
os
ed
 C
D
59
(%
 c
on
tro
l)
0
20
40
60
80
100
siC
si2
si1
**
**
*
3L/AWT K/A
2
M
A
L2
  a
ct
in
 c
om
et
s
/1
00
 μ
m
+ **
*
**
*
**
0
1
2
3
4
5
**
*
**
siC
si2
si1
3L/AWT K/A
150
50
siC si2si1
CD59
INF2
F-actin
Merge
CD59
INF2
F-actin
Merge
K/A
mDia2
hINF2
Bni1p
Endog.
5 μm
Figure 4. Effect of Expression of INF2 Proteins with Point Mutations or Domain Deletions in HepG2 Cells
(A) The alignments show the DAD sequence of human and mouse INF2 (top left panel) and the conservation of Lys1601 in the FH2 domain of Bni1p in the
corresponding position of mDia2 and human INF2 (bottom left panel). The residues mutated to alanine in the 3L/A and K/A INF2-2 mutants are indicated.
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INF2 Mediates Transcytosis and Lumen Formationafter 30 min at 37C, approximately 42% of the lumens formed
already contained transcytosed CD59, in contrast to only 7% in
the GFP-transfected control (Figure 6C). Importantly, the
increased rate of transcytosis promoted by Cdc42L61 was
accompanied by increased dynamics of MAL2, as revealed by
experiments in which the recovery of apical GFP-MAL2 fluores-
cence at the expense of the cytoplasmic pool was measured
(Figure 6D). Providing further evidence of a role for Cdc42
and INF2 in the regulation of MAL2 function in transcytosis,
MAL2 dynamics in normal cells were reduced by Cdc42 or
INF2 silencing (Figure 6D). Moreover, consistent with a role of
INF2 and MAL2 downstream of Cdc42, silencing of INF2 or
MAL2 (Figure 6E) greatly decreased the number of lumens and
the enhanced rate of transcytosis observed in Cdc42L61-ex-
pressing cells (Figures 6F and 6G). The knockdown of either
INF2 or MAL2 caused a modest decrease in the levels of endog-
enous GTP-loaded Cdc42 but not in the total levels of the
protein (Figure 6H). This effect is probably due to the existence
of autoregulatory feedback loops between cell polarization and
Cdc42 activity as described in MDCK cells (Martin-Belmonte
et al., 2007). It is of note that the effect of MAL2 or INF2 depletion
on lumen formation and apical transcytosis is not due to the
observed reduction in Cdc42 activity, as the expression of active
Cdc42L61 in cells knocked down for MAL2 or INF2 did not
correct the defects (Figures 6F and 6G). Therefore, the conclu-
sion from Figures 5 and 6 is that Cdc42 regulates apical transcy-
tosis in HepG2 cells by controlling MAL2 dynamics through INF2
(Figure 6I).
Given the role of INF2 and MAL2 in transcytosis and lumen
formation in HepG2 cells, we investigated the involvement of
these two proteins in the formation of the central lumen in
MDCK cells. MAL2 colocalized with an apical pool of Cdc42 in
cysts of MDCK cells (Figure 7A). Silencing of endogenous
MAL2 (Figure 7B) greatly inhibited the formation of central
lumens in normal MDCK cells (Figures 7C and 7D) and, instead,
multiple intercellular and intracellular lumens appeared (Fig-
ure 7D). Normal formation of central lumens was observed in
MDCK cells stably expressing humanMAL2, which is insensitive
to the siRNA used to deplete the endogenous canine proteinEffect of si1 and si2 transfection on INF2 levels in HepG2 cells expressing INF2-3
transfections, respectively. The expression of a-tubulin was taken as a loading c
(B) The number of intercellular lumens in the different cell cultures transfected w
(C and D) The number of lumens positive for transcytosed CD59 after 90 min of tra
(D). At least 50 lumens were analyzed in each case. Data are expressed as the perc
to those in siC-transfected normal (WT) HepG2 cells (D).
(E) A representative experiment showing the distribution of F-actin, INF2, and
expressing INF2-3L/A or INF2-K/A, respectively, transfected with siC or si1. A si
(F) The number of cytoplasmic MAL2-positive elements with associated actin co
(G–I) HepG2/GFP-MAL2 cells were transfected for 48 hr to express the indicate
analyzed by immunoblotting (G, left panel) and the effect of the exogenous INF2
per assay (G, right panel). The length of filopodial protrusions was determined in a
of a representative experiment and themean from three independent experiments
or MAL2 (I, right panel) at the tip of the filopodia induced by DDID or DDIDDC INF
total number of filopodia examined.
(J) A representative example of the overall distribution of MAL2, INF2, and F-actin
x-y plane is shown. A region of the cell edge is boxed in each case (left panels).
structures is also included. The enlargement of the boxed regions shows details o
filopodial protrusions, which were visualized by F-actin staining (arrowheads). In
The cell on the right serves, therefore, as an internal control of the normal distrib
Data in (B)–(D) and (F)–(I) are summarized as means ± SEM from three independ
Deve(Figures 7B–7D). INF2 silencing in MDCK cells (Figure 7E) basi-
cally reproduced the effect of MAL2 silencing, with a dramatic
drop in the formation of central lumens and the appearance of
multiple inter- and intracellular lumens (Figures 7F and 7G).
Thus, both INF2 and MAL2 are required for the formation of
the central lumen in MDCK cell cysts.
DISCUSSION
The integral membrane MAL2 protein was characterized as an
essential component of the vesicular machinery for apical trans-
cytosis (de Marco et al., 2002). In an attempt to understand how
transcytotic vesicular traffic is regulated, we sought MAL2-inter-
acting proteins and found INF2, a formin of unknown function
(Chhabra and Higgs, 2006) that is a binding partner of MAL2.
The interaction involved the carboxy-terminal (C) region of
INF2, which is not conserved in other formins. At the opposite
end of the molecule, the DID of INF2 interacted with Cdc42
and Rac1 but not RhoA. Consistent with their physical interac-
tion, MAL2 colocalized with a fraction of Cdc42 and INF2 at
the apical region of HepG2 cells. A combination of loss- and
gain-of-function experiments revealed a novel pathway bywhich
Cdc42 binds to INF2, which, in turn, regulates MAL2 dynamics
and, thereby, transcytotic transport to the apical membrane.
The functioning of this pathway is essential for correct lumen
formation in HepG2 cells and organotypic cultures of MDCK
cells.
MAL2 fulfils its transcytotic function by shuttling in tubulove-
sicular structures between the apical zone, which constitutes
its main site of residence, and the cell periphery, where it
encounters internalized cargo that is subsequently ferried in
MAL2-positive transcytotic carriers destined for the apical
surface (de Marco et al., 2006). In the case of the apical MUC1
cargo glycoprotein, a direct interaction with MAL2 has recently
been described (Fanayan et al., 2009). We observed that
silencing of either Cdc42 or INF2 in HepG2 cells slowed down
MAL2 dynamics and greatly diminished the progression of cargo
toward the apical membrane without affecting its internalization.
Glycosylphosphatidylinositol-anchored protein internalizationL/A (top right panel) and INF2-K/A (bottom right panel) in stable and transient
ontrol.
ith the indicated siRNA was quantified by analyzing 100 cells per experiment.
nscytosis (C) and the intensity of CD59 in the positive lumens were determined
entage of CD59-positive lumens (C) or the levels of transcytosed CD59 relative
CD59 after 90 min of CD59 transcytosis in HepG2 cells stably or transiently
ngle confocal x-y plane from the luminal zone is shown.
mets was quantified.
d INF2-2 proteins. The expression levels of INF2, MAL2, and a-tubulin were
-2 proteins on the number of intercellular lumens was quantified in 100 cells
t least 20 filopodia per cell in a total of 25 cells examined per assay. The result
are shown (H). The number of actin filaments with exogenous INF2 (I, left panel)
2-2 was quantified. Data are expressed as the mean percentage relative to the
in cells expressing the indicated exogenous INF2-2 proteins. A single confocal
A Nomarsky image of the boxed region indicating the position of the filopodia
f the distribution of MAL2 (filled arrows) and INF2 (open arrows) at the tip of the
the case of intact INF2-2 transfection, only the cell on the left was transfected.
ution of MAL2 in the unpolarized HepG2 cell population.
ent experiments (*p < 0.05; **p < 0.01; ***p < 0.001). See also Figure S3.
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Figure 5. Cdc42 Binds INF2 and Its
Silencing Impairs Lumen Formation and
Apical Transcytosis
(A) Cell extracts were loaded with GTP analog
GMP-PNP or with GDP and incubated with GST
alone or fused to the indicated N-terminal frag-
ment of INF2 that contains the DID domain. As
controls, the Rho-GTPase binding domains of
rhotekin (RBD) or PAK1 (PBD) were used to detect
active RhoA or Rac1 and Cdc42, respectively. Ten
percent of the original extract was immunoblotted
in parallel.
(B–E) HepG2 cells were transfected with siC or
siRNA specific to RhoA, Rac1, or Cdc42 for 72 hr
and subjected to different processing. Cells were
lysed and subjected to immunoblotting with anti-
bodies to RhoA, Rac1, or Cdc42 antibodies and
with antibodies to INF2 or a-tubulin as controls
(B). The number of intercellular lumens in the
different cell cultures was quantified by analyzing
100 cells per experiment (C). The number of
lumens positive for transcytosed CD59 (D) and
the intensity of CD59 in the positive lumens (E)
were determined after 90 min of transcytosis. At
least 50 lumens were analyzed in (D) and (E).
Data are expressed as the percentage of lumens
positive for transcytosed CD59 (D) or levels of
transcytosed CD59 expressed as the percentage
relative to those in siC-transfected normal
HepG2 cells (E). Data in (C)–(E) are summarized
as means ± SEM from three independent experi-
ments (**p < 0.01; ***p < 0.001).
(F) A representative experiment showing F-actin
staining and the overall distribution of CD59 after
90 min of transcytosis under the different condi-
tions used in (B)–(E) (left and middle panels).
A single confocal x-y plane is shown. The position
of the lumen is indicated by the boxed region. The
enlargements of the boxed regions show details of
the distribution of CD59 and F-actin at the apical
zone (right panels). The arrows and arrowheads
point to CD59 located outside the luminal zone
or in the luminal membrane, respectively.
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INF2 Mediates Transcytosis and Lumen Formationhas been recently shown to be a Cdc42-independent process
that requires expression of flotillin (Ait-Slimane et al., 2009), a
type of raft-associated molecule structurally unrelated to
MAL2. It is of particular note that INF2 silencing produced cargo822 Developmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Inc.retention in endosome structures distant
from the apical membrane, evoking the
effect of MAL2 silencing by which MAL2
appears to control transcytosis remotely
(de Marco et al., 2002). Our results are
in agreement with previous findings
showing the requirement of actin fila-
ments in postendocytic traffic of cargo
prior to the nocodazole-sensitive step
(Maples et al., 1997) and are evidence of
collaboration between the actin and
microtubule cytoskeletons in apical
transcytosis. Although speculative at this
stage, the observation that, in addition toits location at the apical zone, INF2 is predominantly localized in
the endoplasmic reticulum raises the possibility of an involve-
ment of the endoplasmic reticulum in apical transcytosis or other
transport processes. Actin assembly has been shown to power
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Figure 6. Cdc42 Regulates the Number of Lumens and the Rate of Transcytosis in an INF2- and MAL2-Dependent Fashion
(A) The distributions of MAL2, F-actin, and transiently expressed Cdc42L61 were analyzed by confocal microscopy. An image reconstructed from different
confocal planes is shown. The position of the lumen is indicated by the boxed region (left panels). The enlargement of the boxed region shows the distribution
in a single x-y plane of Cdc42, MAL2, and F-actin at the apical region (right panels).
(B and C) HepG2 cells were transfected with DNA constructs expressing GFP alone or fused to the Cdc42L61 or Cdc42N17 mutants and 24 hr later subjected
to different processing. The number of intercellular lumens was quantified by analyzing 100 cells per experiment (B, left panel). The expression levels of the
respective proteins were analyzed by immunoblotting (B, right panel). The number of lumens positive for transcytosed CD59 was estimated in GFP- or
Cdc42L61-GFP-transfected cells after 30, 60, or 90 min of transcytosis and expressed as the percentage relative to the total number of lumens (C, left panel).
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INF2 Mediates Transcytosis and Lumen Formationthe movement of intracellular vesicles and even intracellular
pathogens (Ploubidou and Way, 2001; Taunton, 2001). In vitro
elongation of actin filaments between an immobilized formin
and a second anchor point produces buckled filaments as short
as 0.7 mm, demonstrating that actin polymerization produces
forces > 1 pN (Kovar and Pollard, 2004; Kozlov and Bershadsky,
2004). We have visualized comets formed by short actin fila-
ments decorated with INF2 at their growing end that appear to
push different types of MAL2-positive elements. These actin
comets were practically absent in INF2-silenced cells. It is worth
noting that the expression of the deregulated DDID mutant,
which contains the C-terminal domain responsible for the inter-
action of INF2 with MAL2, but not a similar mutant without
this domain, resulted in MAL2 targeting to the tips of the
INF2-induced actin stress fibers, where it colocalizes with the
deregulated INF2 protein. We therefore propose that assembly
and disassembly of short actin filaments by INF2 provide force
for propelling MAL2-positive vesicle movement to encounter
internalized cargo.
Formins mDia3 (hDia2C) and the couple mDia1 and mDia2 as
effectors of RhoD and RhoB, respectively, show the potential to
modulate endosome trafficking (Fernandez-Borja et al., 2005;
Gasman et al., 2003; Wallar et al., 2007). It has been proposed
that the physiological role of these Drfs is to allow endosome
movement by participating in continuous polymerization-depo-
lymerization cycles of actin filaments (Wallar et al., 2007). The
formin-family Diaphanous Dia1 is required for apical secretion
in epithelial tubes of the Drosophila embryo (Massarwa et al.,
2009). Obviously, mDia1–3 would be responsible for F-actin
assembly, but disassembly would require the participation of
additional proteins with severing and depolymerizing activities.
The participation of such proteins does not appear to be exclu-
sive to the movement of endosomes because cofilin, an actin-
severing protein, has recently been implicated in the regulation
of a population of actin filaments involved in transport of p75
through the direct route from the Golgi (Salvarezza et al.,
2009). A distinctive feature of INF2, compared with the afore-
mentioned Drfs, is its in vitro capacity both to nucleate and depo-
lymerize actin filaments (Chhabra and Higgs, 2006). Therefore,
unlike other formins that would require machinery for disas-
sembly of actin filaments, it appears that INF2 could do the entire
job. Consistent with the requirement for actin assembly and
disassembly in INF2 function in transcytosis, we found that
INF2 proteins with mutations that abrogate the actin depolymer-The distributions of CD59 and F-actin after 10 and 30 min of transcytosis are show
The arrows and the arrowheads point to CD59 located outside the luminal zone
(D) HepG2/Cherry-MAL2 cells expressing siC, siINF2 (si1), or siCdc42 for 72 hr or
of apical MAL2 fluorescence after photobleaching of MAL2 at the apical area.
experiments.
(E) HepG2 cells were transfected with siC or two different siRNAs targeted to MA
a-tubulin. The levels of MAL2 expression are expressed as percentages relative
(F and G) HepG2 cells were transfected for 72 hr with siRNA to INF2 (si1) or to M
quantified by analyzing 100 cells per experiment (F). The number of lumens posi
result is expressed as the percentage relative to the total number of lumens und
(H) HepG2 cells were transfected with siC or an siRNA pool targeted to INF2 or M
with the GTPase binding domain of PAK followed by immunoblotting with anti-Cd
Cdc42/total Cdc42 relative to siC-transfected cells.
(I) Schematic model of the proposed role of Cdc42 and INF2 in the formation an
Data in (B)–(D) and (F)–(H) are summarized as means ± SEM from three indepen
824 Developmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Inization activity of INF2 or the actin polymerization activity of other
formins were unable to reconstitute transcytosis in cells with
depleted levels of endogenous INF2, whereas this was success-
fully achieved by intact INF2.
Unlike HepG2 cells that form lateral lumens, MDCK cells
grown in three-dimensional cultures orient their apical surface
to assemble a central lumen. A current model of control of
epithelial morphogenesis proposes that Cdc42 is recruited to
the apical surface by annexin 2, which, in turn, is recruited by
PTEN-mediated apical segregation of PtdIns(4,5)P2. Once at
the apical membrane, Cdc42 can recruit Par6, a member of
the Par3/Par6/aPKC complex, which controls apical membrane
formation (Martin-Belmonte et al., 2007). Cdc42 silencing
impairs the formation of the central lumen in MDCK cysts and,
instead, multiple intracellular and intercellular lumens are formed
(Martin-Belmonte et al., 2007). Silencing of INF2 or MAL2 in
MDCK cells recapitulated the effect of Cdc42 silencing on lumen
formation. In contrast, we did not observe formation of intracel-
lular or intercellular lumens in HepG2 cells with silenced levels of
Cdc42, INF2, or MAL2. An important difference between HepG2
and MDCK cells is that apical transport of proteins attached to
the membrane by a single anchor exclusively relies on the trans-
cytotic pathway in HepG2 cells, whereas direct routes coexist
with the transcytotic pathway in MDCK cells. Therefore, in the
absence of apical transcytosis, MDCK cells can still use the
direct route for apical targeting and form intracellular or intercel-
lular lumens, whereas this process is not possible in HepG2
cells.
INF2 mutations have recently been implicated in an auto-
somal-dominant form of focal segmental glomerulosclerosis
(Brown et al., 2010), a kidney disease characterized by dysregu-
lation of podocyte function and alterations in the podocyte cyto-
skeleton. As INF2 is ubiquitously expressed, our results on INF2
function could be useful for understanding the role of INF2 in
other cell types under normal or pathological conditions. In
summary, our findings suggest that, in addition to acting in other
pathways crucial for correct lumen formation (Georgiou et al.,
2008; Jaffe et al., 2008; Martin-Belmonte et al., 2007), Cdc42
governs a novel pathway dedicated to the regulation of apical
transcytosis by which Cdc42 controls INF2, which, in turn, regu-
lates MAL2 dynamics through the formation of actin comets that
promote the formation of MAL2-positive elements and appear to
propel their movement. This process is essential for correct
lumen formation in HepG2 and MDCK cells.n (C, right panels). A single confocal x-y plane from the luminal zone is shown.
or in the luminal membrane, respectively.
expressing Cdc42L61 for 24 hr were assayed at different times for the recovery
Data are expressed as percentage recovery ± SEM from five independent
L2. After 72 hr, cell extracts were analyzed with antibodies to MAL2, INF2, or
to siC-transfected cells.
AL2 alone or together with Cdc42L61. The number of intercellular lumens was
tive for transcytosed CD59 was analyzed after 30 min of transcytosis and the
er each condition. At least 50 lumens were analyzed in each case (G).
AL2, respectively. After 72 hr, active Cdc42 was detected by pull-down assay
c42 antibodies. Data are expressed as the mean percentage ± SEM of active
d movement of MAL2-positive vesicular carriers.
dent experiments (**p < 0.01; ***p < 0.001).
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Figure 7. MAL2 and INF2 Are Necessary for Central Lumen Morphogenesis in Three-Dimensional Cultures of MDCK Cells
(A) MDCK cell cysts expressing Cdc42-GFP were grown for 72 hr and then stained for endogenous MAL2 and nuclei (left panel). The arrowheads in the
enlargement of the boxed region show regions of colocalization of MAL2 with the apical pool of Cdc42 (right panels).
(B) Normal MDCK cells or MDCK cells stably expressing human MAL2 (hMAL2) were transfected with control siRNA or siRNA to canine MAL2, plated for 72 hr,
and analyzed by western blot with antibodies that recognize both canine and human MAL2 or with antibodies to a-tubulin. Human MAL2 expression was not
affected by the siRNA targeted to canine MAL2. The percentage of MAL2 expression under the different conditions used is indicated.
(C) Normal MDCK cells or MDCK cells stably expressing human MAL2 were transfected with control siRNA or siRNA to canine MAL2 for 24 hr and grown in
Matrigel for 72 hr. Quantification of the number of cysts with normal central lumens in control MDCK cells and MDCK cells knocked down for MAL2 is shown.
(D) Normal MDCK cells treated as in (C) were fixed and stained for the apical marker Gp135, MAL2, and nuclei. MAL2-silenced cells showed impaired lumen
morphogenesis and formed cysts with multiple small lumens (arrowhead).
(E) Normal MDCK cells were transfected with control siRNA or siRNA to canine INF2 for 24 hr, plated for 72 hr, and analyzed by western blot with anti-INF2
antibodies or with antibodies to a-tubulin. The percentage of INF2 expression under the different conditions used is indicated.
(F) Normal MDCK cells transfected with control siRNA or siRNA to canine INF2 for 24 hr were grown in Matrigel for 72 hr. The number of cysts with normal central
lumens in control MDCK cells and MDCK cells knocked down for INF2 was quantified. Data are represented as the percentage of cysts with central lumen.
(G) Normal MDCK cells treated as in (F) were fixed and stained for the apical marker Gp135 and INF2. Cells were then fixed and stained for the apical marker
Gp135, endogenous INF2, and nuclei. INF2-silenced cells showed impaired lumen morphogenesis and formed cysts with multiple small lumens (arrowheads).
Data in (C) and (F) are summarized as means ± SEM from three independent experiments. More than 100 cysts were quantified in each experiment (**p < 0.01).
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Yeast Two-Hybrid Screening
Yeast two-hybrid screening and direct interaction testing were performed as
previously described (Fanayan et al., 2009). Please refer to Supplemental
Information for further details of the experimental procedures used.
Cloning of Human INF2 cDNA and Generation of INF2 cDNA
Constructs
Sequencing of several cDNAsmapping to the human INF2 locus obtained from
the IMAGE Consortium (http://image.hudsonalpha.org) allowed the identifica-
tion of two overlapping halves of the human INF2-2 cDNA coding sequence
(IMAGE clones 2223558 and 3343082). These partial cDNAs were subse-Devequently fused to generate a single length of cDNA of 4.6 kb, which includes
the complete coding sequence of INF2-2 and a part of its 50 and 30 untranslated
flanking regions. The rest of the DNA constructs used are described in Supple-
mental Information.
Cell Cultures, siRNA, and Transfections
Human hepatoma HepG2 cells were grown in high-glucose Dulbecco’s modi-
fied Eagle’s medium supplemented with 5% fetal bovine serum (Sigma). For
stable expression of exogenous proteins, transfected cells were selected by
treatment with 0.5 mg/ml G-418 sulfate for at least 4 weeks after transfection.
Positive cell clones were maintained in drug-free medium. After several
passages in this medium, >90% of cells retained expression of the exogenous
product. To prepare cysts in Matrigel, MDCK cells grown in Petri dishes werelopmental Cell 18, 814–827, May 18, 2010 ª2010 Elsevier Inc. 825
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INF2 Mediates Transcytosis and Lumen Formationbrought to a single-cell suspension (43 104 cells/ml) in 2%Matrigel, plated in
coverglass chambers, and grown for 72 hr. The sequence of the siRNA hetero-
duplexes and the transfection conditions used are detailed in Supplemental
Experimental Procedures.Confocal Microscopic Analysis
The procedure for cell immunolabeling is detailed in Supplemental Information.
Images were obtained by confocal microscopy using an LSM510 META
system (Carl Zeiss) coupled to an inverted Axiovert 200 microscope. For
each sample, medial optical slices of 50 different polarized cells were
recorded. HepG2 intercellular lumens (bile canaliculi) were visualized on
phase-contrast acquisitions and by F-actin staining. We used Huygens 3.0
software (Scientific Volume Imaging) for deconvolution and ImageJ (http://
rsb.info.nih.gov/ij) for colocalization graphics. NIH Image software was used
to quantify the intensity of fluorescence (mean intensity of fluorescence per
pixel). Images were exported in TIFF format, and their brightness and contrast
were optimized with Adobe Photoshop.Transcytosis Assay
HepG2 cells were incubated with mouse mAb to CD59 at 4C for 30 min. After
extensive washes, cells were incubated at 37C for different times in normal
medium. At each time, the cells were washed, fixed, and analyzed by immuno-
fluorescence microscopy with fluorescent anti-mouse IgG secondary anti-
bodies (Invitrogen). Lumens were scored as positive for transcytosed CD59
when the intensity of CD59 staining was greater than the mean at 0 min +
1.5 3 SEM.Time-Lapse Videomicroscopic Analysis and FRAP Assays
Time-lapse videomicroscopy of the transcytosis process was as previously
described (de Marco et al., 2006). Cell images were captured at 15 min inter-
vals. Images were analyzed with MetaMorph imaging software (Molecular
Devices). FRAP analysis was done with an inverted confocal laser LSM710
scanning microscope (Carl Zeiss).Pull-Down and Coimmunoprecipitation Analyses
For pull-down experiments, HepG2 cell lysates were incubated at 4C in assay
buffer with 10 mg of GST proteins immobilized on GSH-Sepharose beads (GE
Healthcare Life Sciences). For coimmunoprecipitation analysis, lysates were
precleared with a control antibody bound to protein G Sepharose and then
incubated overnight at 4C with anti-MAL2 antibody complexed to protein G
Sepharose. Sepharose beads were extensively washed and bound proteins
were analyzed by immunoblotting. Please refer to Supplemental Information
for further details.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one movie and can be found with this article online at
doi:10.1016/j.devcel.2010.04.001.ACKNOWLEDGMENTS
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